ENDP Endo International plc

2.26
+0.03  (+1%)
Previous Close 2.23
Open 2.29
Price To Book -0.87
Market Cap 511,646,557
Shares 223,103,410
Volume 3,347,503
Short Ratio
Av. Daily Volume 5,737,153

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Advisory Committee Meeting March 14, 2017 voted 18 to eight that the benefits of reformulated OPANA ER no longer outweigh its risks.
OPANA ER
Management of pain
Approved October 26, 2015.
BEMA Buprenorphine
Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate
CRL issued May 30 2013. Approved March 6 2014.
AVEED (testosterone undecanoate) intramuscular injection
Men diagnosed with hypogonadism
BLA filing 2H 2019.
XIAFLEX (collagenase clostridium histolyticum) - RELEASE
Edematous fibrosclerotic panniculopathy (“cellulite”)